Intellia Therapeutics NTLA announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation ...

Intellia Therapeutics (NTLA) announced that the U.S. Food and Drug Administration, FDA, has granted Regenerative Medicine Advanced Therapy, ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intellia Therapeutics (NTLA – Research Report) ...

Epicrispr Biotechnologies has raised $68m in the initial close of its Series B financing round to commence the clinical trial ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

PNC Financial Services Group Inc. reduced its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 69.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 5,227 shares ...

Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nineteen research firms that are currently covering the firm, ...

Intellia Therapeutics' stock is downgraded to HOLD due to market skepticism and lack of near-term catalysts despite promising Phase 3 trials for HAE and ATTR. NTLA-2002, Intellia's CRISPR/Cas9 ...

Using CRISPR/Cas9 gene-editing technology, Intellia Therapeutics develops gene-editing treatments for genetic diseases. The company's lead programs, NTLA-2001 and NTLA-2002, target transthyretin ...

CAMBRIDGE, Mass. - Intellia Therapeutics, Inc. (NASDAQ:NTLA), a pioneer in CRISPR-based gene editing treatments with a market capitalization of $904 million, has secured a Regenerative Medicine ...

The industry’s first single drum roller simulation training product integrates with CM Labs’ Intellia training platform and is designed to equip new operators with essential skills.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...